food-and-drug-administration

Documents about food-and-drug-administration

• 21 CFR Part 80 — Color Additive Certification#506726Code of Federal Regulations (eCFR)
• 21 CFR Part 290 — Controlled Drugs#506809Code of Federal Regulations (eCFR)
• 21 CFR Part 600 — Biological Products: General#506869Code of Federal Regulations (eCFR)
• 21 CFR Part 822 — Postmarket Surveillance#506895Code of Federal Regulations (eCFR)
• 21 CFR Part 868 — Anesthesiology Devices#506902Code of Federal Regulations (eCFR)
• 21 CFR Part 870 — Cardiovascular Devices#506903Code of Federal Regulations (eCFR)
• 21 CFR Part 872 — Dental Devices#506904Code of Federal Regulations (eCFR)
• 21 CFR Part 882 — Neurological Devices#506909Code of Federal Regulations (eCFR)
• 21 CFR Part 886 — Ophthalmic Devices#506911Code of Federal Regulations (eCFR)
• 21 CFR Part 888 — Orthopedic Devices#506912Code of Federal Regulations (eCFR)
• 21 CFR Part 892 — Radiology Devices#506914Code of Federal Regulations (eCFR)
• 21 CFR Part 895 — Banned Devices#506915Code of Federal Regulations (eCFR)
• 21 CFR Part 1150 — User Fees#506934Code of Federal Regulations (eCFR)
• 21 CFR Part 10 — Administrative Practices and Procedures#506705Code of Federal Regulations (eCFR)
• 21 CFR Part 1002 — Records and Reports#506919Code of Federal Regulations (eCFR)
• 21 CFR Part 113 — Thermally Processed Low-Acid Foods Packaged in Hermetically Sealed Containers#506742Code of Federal Regulations (eCFR)
• Disseminated Intravascular Coagulation Following Idarucizumab and Andexanet Alfa: Assessment of a Signal of Disproportionate Reporting From the Food and Drugs Administration Adverse Event Reporting System (FAERS) Database#172253Springer Nature OA
• 21 CFR Part 556 — Tolerances for Residues of New Animal Drugs in Food#506860Code of Federal Regulations (eCFR)
• 21 CFR Part 589 — Substances Prohibited from Use in Animal Food or Feed#506868Code of Federal Regulations (eCFR)
• 21 CFR Part 4 — Regulation of Combination Products#506702Code of Federal Regulations (eCFR)
• 21 CFR Part 11 — Electronic Records; Electronic Signatures#506706Code of Federal Regulations (eCFR)
• 21 CFR Part 12 — Formal Evidentiary Public Hearing#506707Code of Federal Regulations (eCFR)
• 21 CFR Part 17 — Civil Money Penalties Hearings#506712Code of Federal Regulations (eCFR)
• 21 CFR Part 50 — Protection of Human Subjects#506717Code of Federal Regulations (eCFR)
• 21 CFR Part 300 — General#506811Code of Federal Regulations (eCFR)
• 21 CFR Part 610 — General Biological Products Standards#506873Code of Federal Regulations (eCFR)
• 21 CFR Part 740 — Cosmetic Product Warning Statements#506882Code of Federal Regulations (eCFR)
• 21 CFR Part 803 — Medical Device Reporting#506885Code of Federal Regulations (eCFR)
• 21 CFR Part 812 — Investigational Device Exemptions#506891Code of Federal Regulations (eCFR)
• 21 CFR Part 830 — Unique Device Identification#506896Code of Federal Regulations (eCFR)
• 21 CFR Part 876 — Gastroenterology-Urology Devices#506906Code of Federal Regulations (eCFR)
• 21 CFR Part 890 — Physical Medicine Devices#506913Code of Federal Regulations (eCFR)
• 21 CFR Part 900 — Mammography#506917Code of Federal Regulations (eCFR)
• 21 CFR Part 573 — Food Additives Permitted in Feed and Drinking Water of Animals#506864Code of Federal Regulations (eCFR)
• 21 CFR Part 2 — General Administrative Rulings and Decisions#506700Code of Federal Regulations (eCFR)
• 21 CFR Part 864 — Hematology and Pathology Devices#506900Code of Federal Regulations (eCFR)
• 21 CFR Part 866 — Immunology and Microbiology Devices#506901Code of Federal Regulations (eCFR)
• 21 CFR Part 884 — Obstetrical and Gynecological Devices#506910Code of Federal Regulations (eCFR)
• Perceptions of the Proposed Food and Drug Administration Graphic Cigarette Warnings Among Adults Who Smoke on a Nondaily or Daily Basis: A Within-Subjects Experiment#5221Europe PMC
• A Study to Evaluate the Food Effect on Drug Availability, Pharmacokinetic (PK) Properties, Safety and Tolerability of Two Different Dose Combination Therapy of Saxagliptin/Dapagliflozin/Metformin Extended-release (XR) Against Individual Component Co-administration.#136275ClinicalTrials.gov
• Considerations for the Use of Artificial Intelligence To Support Regulatory Decision-Making for Drug and Biological Products; Draft Guidance for Industry; Availability; Comment Request#512201Federal Register
• 21 CFR Part 15 — Public Hearing Before the Commissioner#506710Code of Federal Regulations (eCFR)
• 21 CFR Part 54 — Financial Disclosure by Clinical Investigators#506718Code of Federal Regulations (eCFR)
• 21 CFR Part 251 — Section 804 Importation Program#506808Code of Federal Regulations (eCFR)
• 21 CFR Part 310 — New Drugs#506812Code of Federal Regulations (eCFR)
• 21 CFR Part 315 — Diagnostic Radiopharmaceuticals#506815Code of Federal Regulations (eCFR)
• 21 CFR Part 316 — Orphan Drugs#506816Code of Federal Regulations (eCFR)
• 21 CFR Part 317 — Qualifying Pathogens#506817Code of Federal Regulations (eCFR)
• 21 CFR Part 680 — Additional Standards for Miscellaneous Products#506877Code of Federal Regulations (eCFR)
• 21 CFR Part 810 — Medical Device Recall Authority#506890Code of Federal Regulations (eCFR)